Related Experiment Video
Updated: Dec 23, 2025

Quantitative Analysis of Autophagy using Advanced 3D Fluorescence Microscopy
Published on: May 3, 2013
Targeting ROS-Mediated Crosstalk Between Autophagy and Apoptosis in Cancer
Lixia Gao1, Jenni Loveless2, Chloe Shay3
1International Academy of Targeted Therapeutics and Innovation, Chongqing University of Arts and Sciences, Chongqing, P. R. China.
Abstract:
The control of crosstalk between autophagy and apoptosis in tumor cells can remove a critical barrier to comprehensive and efficacious treatment for cancer. Reactive oxygen species (ROS), by-products of redox homeostasis, are critical for regulating the balance between autophagy and apoptosis in cancer cells upon different drug treatments and gene modifications. The mechanisms and consequences involved in ROS-mediated crosstalk between apoptosis and autophagy are extremely complex in cancer cells. Here, we mainly discuss the closely linked relationship between ROS levels, autophagy, and apoptosis in cancer therapy.
Insights
Controlling the interplay between autophagy and apoptosis in cancer cells, particularly through reactive oxygen species (ROS), is key to effective cancer treatment. Understanding ROS-mediated crosstalk is crucial for developing novel cancer therapies.
Area of Science:
- Oncology
- Cellular Biology
- Biochemistry
Background:
- Autophagy and apoptosis are critical cell death pathways in cancer.
- Crosstalk between these pathways presents a challenge in cancer therapy.
- Reactive oxygen species (ROS) play a regulatory role in this crosstalk.
Purpose of the Study:
- To discuss the complex relationship between ROS levels, autophagy, and apoptosis in cancer.
- To highlight the significance of controlling ROS-mediated crosstalk for cancer treatment efficacy.
Main Methods:
- Literature review and synthesis of existing research on ROS, autophagy, and apoptosis in cancer.
- Analysis of mechanisms underlying ROS-mediated crosstalk between cell death pathways.
Main Results:
- ROS are central regulators of the balance between autophagy and apoptosis in tumor cells.
- Dysregulation of ROS levels impacts cancer cell fate under various treatments.
- The complexity of ROS-mediated crosstalk poses challenges but also therapeutic opportunities.
Conclusions:
- Targeting the ROS-mediated crosstalk between autophagy and apoptosis is a promising strategy for overcoming therapeutic resistance in cancer.
- Further research into these intricate mechanisms can lead to more efficacious cancer treatments.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
09:51Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
The Intrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
Apoptosis